39th Street OverpassRare KC logoHiguchi Biosciences Center

IAMI partners with BioNovus to develop bladder cancer drug

IAMI and BioNovus join to speed biotech, pharma commercialization on bladder cancer drug. Read More

RareKC Leadership Summit 2017 - Thursday, March 2 at 8:00 a.m.

Join families and community leaders to discuss the unique challenges and unmet needs of Rare Disease as we advance medical innovation in Kansas City. Read more.

Higuchi Biosciences Center announces the 2016 J.R. and Inez Jay Fund research awards

Three projects were selected this year to receive the 2016 J.R. and Inez Jay Fund research award. Learn more

Institute for Advancing Medical Innovation

The Institute for Advancing Medical Innovation (IAMI) serves as a national model for philanthropy, industry and universities to collaborate in advancing university innovations in life sciences by:

Vision Change the standard of care for pediatric, adolescent and adult patients living with diseases including cancer and rare diseases.

Mission Discover and develop pharmaceuticals and diagnostics with a clear path to market.

Core Hypothesis The investment in high potential academic projects with industry-experienced leadership will enhance the yield of commercial products that benefit patients.

Photo of children
Children's Mercy Kansas City
Together, IAMI and Children's Mercy Kansas City have advanced several discoveries to patient treatments.

Frontiers logo
Frontiers Heartland Institute
IAMI and Frontiers accelerate the process of lab discoveries becoming patient treatments.
researchers in a lab
KU Cancer Center
Innovation and discovery drive the partnership between The University of Kansas Cancer Center and IAMI.

KU Endowment Building
KU Endowment
KU Endowment financially supports IAMI to bring new drugs and treatments to the market.
Last modified: Feb 24, 2017
About Us

IAMI is based on strong leadership, which includes:

• External advisory board of national and international experts

• Internal leadership of experts from drug development and medical device industries, foundations, and academic institutions

• Network of alumni and biotechnology professionals supporting the mission through expertise and passion